Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 2/20 | 0.50 |
| ▸ | GSR | P00390 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | PNMT | P11086 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.43 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 3/20 | 0.42 |
| ▸ | HTR7 | P34969 | 2/20 | 0.42 |
| ▸ | HTR2C | P28335 | 2/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL813189 | 0.84 | CA12 (0.46) | SRD5A2GSRNPC1RAB9APNMT | |
| SCHEMBL31158183 | 0.83 | HSP90AA1 (0.50) | SRD5A2GSRNPC1RAB9APNMT | |
| SCHEMBL3720118 | 0.83 | HSP90AA1 (0.50) | SRD5A2GSRNPC1RAB9APNMT | |
| SCHEMBL3706194 | 0.82 | HSP90AA1 (0.49) | SRD5A2GSRNPC1RAB9APNMT | |
| SCHEMBL30961640 | 0.82 | HSP90AA1 (0.49) | SRD5A2GSRNPC1RAB9APNMT | |
| SCHEMBL8928039 | 0.82 | SRD5A2 (0.49) | SRD5A2GSRNPC1RAB9APNMT | |
| SCHEMBL29022366 | 0.78 | SRD5A2 (0.56) | SRD5A2GSRNPC1RAB9AHSP90AA1 | |
| SCHEMBL9161973 | 0.78 | HSP90AA1 (0.49) | SRD5A2NPC1RAB9APNMTHSP90AA1 | |
| SCHEMBL27904131 | 0.77 | SRD5A2 (0.44) | SRD5A2GSRNPC1RAB9APNMT | |
| SCHEMBL1261848 | 0.77 | PNMT (0.50) | SRD5A2NPC1RAB9APNMTCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10023689-B2 | Functional biodegradable polymers | THE UNIVERSITY OF AKRON | 2018-07-17 | — | — | US | claimed |
| US-20160229952-A1 | FUNCTIONAL BIODEGRADABLE POLYMERS | NATIONAL SCIENCE FOUNDATION | 2016-08-11 | — | — | US | claimed |
| US-20130184429-A1 | FUNCTIONAL BIODEGRADABLE POLYMERS | THE UNIVERSITY OF AKRON (US) | 2013-07-18 | — | — | US | claimed |
| EP-2598552-A1 | FUNCTIONAL BIODEGRADABLE POLYMERS | University Of Akron (US) | 2013-06-05 | — | — | EP | claimed |
| WO-2012015481-A1 | FUNCTIONAL BIODEGRADABLE POLYMERS | UNIVERSITY OF AKRON (US) | 2012-02-02 | — | — | WO | claimed |
| US-20090130739-A1 | Deactivation of mineral encapsulated nanobacteria | AMERICAN STERILIZER COMPANY (US) | 2009-05-21 | — | — | US | claimed |
| US-12005089-B2 | CVS transplantation for treatment of bacterial vaginosis | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-06-11 | — | — | US | disclosed |
| US-10351504-B1 | Synthesis of hydroxyfluorene-carboxilic acid and esters thereof | MANDAVA NAGA BHUSHAN (US) | 2019-07-16 | — | — | US | disclosed |
| US-10023689-B2 | Functional biodegradable polymers | THE UNIVERSITY OF AKRON | 2018-07-17 | — | — | US | disclosed |
| US-20160279182-A1 | CVS TRANSPLANTATION FOR TREATMENT OF BACTERIAL VAGINOSIS | THE JOHNS HOPKINS UNIVERSITY | 2016-09-29 | — | — | US | disclosed |
| US-20160229952-A1 | FUNCTIONAL BIODEGRADABLE POLYMERS | NATIONAL SCIENCE FOUNDATION | 2016-08-11 | — | — | US | disclosed |
| US-20130184429-A1 | FUNCTIONAL BIODEGRADABLE POLYMERS | THE UNIVERSITY OF AKRON (US) | 2013-07-18 | — | — | US | disclosed |
| EP-2598552-A1 | FUNCTIONAL BIODEGRADABLE POLYMERS | University Of Akron (US) | 2013-06-05 | — | — | EP | disclosed |
| US-20090130739-A1 | Deactivation of mineral encapsulated nanobacteria | AMERICAN STERILIZER COMPANY (US) | 2009-05-21 | — | — | US | disclosed |
| EP-1917043-A2 | DEACTIVATION OF MINERAL ENCAPSULATED NANOBACTERIA | Steris, Inc. (US) | 2008-05-07 | — | — | EP | disclosed |
| WO-2007145608-A2 | DEACTIVATION OF MINERAL ENCAPSULATED NANOBACTERIA | STERIS, INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| US-20060270571-A1 | Deactivation of mineral encapsulated nanobacteria | AMERICAN STERILIZER COMPANY | 2006-11-30 | — | — | US | disclosed |
| EP-0934076-A1 | SOLID PHASE LIPOGLYCOPEPTIDE LIBRARY, COMPOSITIONS AND METHODS | Intercardia, Inc. (US) | 1999-08-11 | — | — | EP | disclosed |
| EP-0934076-A4 | — | — | 1999-08-11 | — | — | EP | disclosed |
| WO-1997034623-A1 | SOLID PHASE LIPOGLYCOPEPTIDE LIBRARY, COMPOSITIONS AND METHODS | TRANSCELL TECHNOLOGIES, INC. (US) | 1997-09-25 | — | — | WO | disclosed |